Vera Therapeutics, Inc. (VERA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

64.23M
Year ended 2025-12-31
+34.2%
3-year compound annual growth
2021-12-31: 13.44M2022-12-31: 26.57M2023-12-31: 42.71M2024-12-31: 55.33M2025-12-31: 64.23M64.23M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3164.23M+16.1%2026-02-26, From 2025-01-01
2024-12-3155.33M+29.5%2026-02-26, From 2024-01-01
2023-12-3142.71M+60.7%2026-02-26, From 2023-01-01
2022-12-3126.57Mn/c2024-03-27, From 2022-01-01
2021-12-3113.44Mn/a2023-03-28, From 2021-01-01